Indeed, existing evidence implicates excessive MAP-kinase/NFκβ pathway activity in NEC (60, 77, 78), BPD (79–82), and ROP (83, 84), although these studies have not provided information on cell type specificity. Here, NFKB1 is linked to bronchopulmonary dysplasia.